The immune effector responses against tumor cells involve activity by several cellular constituents: (i) T cells carry out immunologic surveillance, then proliferates and destroys tumor cells after recognizing tumor-associated antigens in combination with major histocompatibility complex (MHC) molecules. The gene discussed is HLA-C; the disease is neoplasm.